| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3084 | |||||||||||||||||||||||
| Submitter : | Ms. Mary Steuer | Date & Time: | 12/14/2006 11:12:48 | |||||||||||||||||||||
| Organization : | Ms. Mary Steuer | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Re: Vaccines: Dear FDA, I am strongly opposed to developing vaccines from aborted cell lines. I prefer that vaccines be developed from other sources. Thank you, Mary | ||||||||||||||||||||||||